-
Of note, this publication is a review article and not original science. Because of its efficacy and convenience, DMPA has been used by millions of women in the United States and around the world.
-
The lift study (Long-Term Intervention on Fractures with Tibolone) was a randomized, placebo-controlled multicenter trial in 22 countries of tibolone, 1.25 mg, given daily over 3 years.
-
The objective of this study was to examine and compare the clinical behavior and outcome of uterine carcinosarcoma relative to grade 3 endometrioid carcinoma.
-
Fetal fibronectin is now being used in many hospitals to separate out those with preterm contractions (PTCs) who are in true labor from those with contractions who are not (and, therefore, not requiring tocolytics or hospitalization).
-
In this issue: Some women with DVT may stop warfarin after six months; Vytorin and cancer; preventing recurrent stroke; and FDA news.
-
Newcomb and colleagues reported breast cancer mortality in the Collaborative Breast Cancer Study Cohort, a prospective cohort of 12,269 postmenopausal women from Wisconsin, Massachusetts, or New Hampshire.
-
-
Between March, 2005 and June 2007, 1622 consecutive patient charts at Temple University Hospital were reviewed to determine whether prophylactic antibiotics were used appropriately with regard to antibiotic choice, timing of administration, and postoperative cessation of antibiotics.
-
The current classification for endometrial cancer incorporates the histological assessment of the regional lymph node to assign stage.
-
Two clinical trials compared rivaroxaban vs enoxaparin prophylactic treatment to prevent venous thromboembolism (VTE) after total hip or knee arthroplasty.
